BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26992663)

  • 1. Potential Therapeutic Aspects of Alarmin Cytokine Interleukin 33 or Its Inhibitors in Various Diseases.
    Arshad MI; Khan HA; Noel G; Piquet-Pellorce C; Samson M
    Clin Ther; 2016 May; 38(5):1000-1016.e1. PubMed ID: 26992663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.
    Rostan O; Arshad MI; Piquet-Pellorce C; Robert-Gangneux F; Gangneux JP; Samson M
    Infect Immun; 2015 May; 83(5):1738-48. PubMed ID: 25712928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Invariant NKT Cells in Sterile Inflammation: The Possible Contribution of the Alarmin/Cytokine IL-33.
    Ferhat MH; Robin A; Barbier L; Thierry A; Gombert JM; Barbarin A; Herbelin A
    Front Immunol; 2018; 9():2308. PubMed ID: 30374349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity.
    Cayrol C
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
    Cayrol C; Girard JP
    Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.
    Schwartz C; O'Grady K; Lavelle EC; Fallon PG
    Eur J Immunol; 2016 May; 46(5):1091-100. PubMed ID: 27000936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity.
    Liu Q; Turnquist HR
    Curr Opin Organ Transplant; 2016 Feb; 21(1):45-52. PubMed ID: 26709577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine expression and barrier disruption in human corneal epithelial cells induced by alarmin released from necrotic cells.
    Fukuda K; Ishida W; Miura Y; Kishimoto T; Fukushima A
    Jpn J Ophthalmol; 2017 Sep; 61(5):415-422. PubMed ID: 28725984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation of airway epithelium cell activation by mesenchymal stromal cells ameliorates house dust mite-induced airway inflammation in mice.
    Duong KM; Arikkatt J; Ullah MA; Lynch JP; Zhang V; Atkinson K; Sly PD; Phipps S
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):615-24. PubMed ID: 25789608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 33 is a guardian of barriers and a local alarmin.
    Martin NT; Martin MU
    Nat Immunol; 2016 Feb; 17(2):122-31. PubMed ID: 26784265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.
    Matsuzaki G; Umemura M
    Microbiol Immunol; 2018 Jan; 62(1):1-13. PubMed ID: 29205464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 Family Cytokines in Liver Diseases.
    Tsutsui H; Cai X; Hayashi S
    Mediators Inflamm; 2015; 2015():630265. PubMed ID: 26549942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alarmin interleukin-33 drives protective antiviral CD8⁺ T cell responses.
    Bonilla WV; Fröhlich A; Senn K; Kallert S; Fernandez M; Johnson S; Kreutzfeldt M; Hegazy AN; Schrick C; Fallon PG; Klemenz R; Nakae S; Adler H; Merkler D; Löhning M; Pinschewer DD
    Science; 2012 Feb; 335(6071):984-9. PubMed ID: 22323740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-induced expression of the alarmin interleukin 33 can be suppressed by galacto-oligosaccharides.
    Verheijden KA; Akbari P; Willemsen LE; Kraneveld AD; Folkerts G; Garssen J; Fink-Gremmels J; Braber S
    Int Arch Allergy Immunol; 2015; 167(2):127-36. PubMed ID: 26304032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alarmin Cytokines as Central Regulators of Cutaneous Immunity.
    Hasegawa T; Oka T; Demehri S
    Front Immunol; 2022; 13():876515. PubMed ID: 35432341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichotomous function of IL-33 in health and disease: From biology to clinical implications.
    Braun H; Afonina IS; Mueller C; Beyaert R
    Biochem Pharmacol; 2018 Feb; 148():238-252. PubMed ID: 29309756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sceptridium ternatum attenuates allergic contact dermatitis-like skin lesions by inhibiting T helper 2-type immune responses and inflammatory responses in a mouse model.
    Lim D; Kim MK; Jang YP; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):288-97. PubMed ID: 26150208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
    Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
    J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.